Bengt Norvik
Amministratore Delegato presso Markett Affärsutveckling AB
Provenienza dei contatti di primo grado di Bengt Norvik
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
6
| Public Company | Pharmaceuticals: Major | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Bengt Norvik tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer | |
| ABLIVA AB | Pharmaceuticals: Major | Director/Board Member | |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Corporate Officer/Principal | |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
| ALLENEX AB | Biotechnology | Director of Finance/CFO | |
| Chalmers University of Technology | College/University | Graduate Degree | |
| Stockholm School of Economics | College/University | Graduate Degree Masters Business Admin | |
| University of Uppsala | College/University | Graduate Degree Doctorate Degree | |
| NEXSTIM PLC | Medical Specialties | Corporate Officer/Principal | |
| Royal Institute of Technology | College/University | Doctorate Degree | |
| Umea Universitet | College/University | Graduate Degree | |
Ernst & Young AB
 Ernst & Young AB Miscellaneous Commercial ServicesCommercial Services Ernst & Young AB provides tax advisory, auditing, and accounting services. It also offers support and advice on risk management, information technology security, and financial and business management. The company was founded in 1949 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
iNovacia AB
 iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| KANCERA AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
CareDx AB
 CareDx AB Medical SpecialtiesHealth Technology CareDx AB develops reagents and kits for low and high resolution human leukocyte antigen typing. Its products include Olerup SSP, Olerup QTYPE, Olerup XM-ONE, Olerup SBT and Olerup Gamma-Type. The comaony was founded by Olle Olerup in 1992 and is headquartered in Saltsjobaden, Sweden. | Medical Specialties | Director of Finance/CFO | |
| Linköping Institute of Technology | College/University | Masters Business Admin | |
| KONTIGO CARE AB | Medical Specialties | Director of Finance/CFO | |
| DICOT PHARMA AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Excore AB
 Excore AB Financial ConglomeratesFinance Excore AB provides investment services. The private company is based in Stockholm, Sweden. Daniel Lifveredson has been the CEO of the Swedish company since 1998. | Financial Conglomerates | Chief Executive Officer | |
Amylonix AB
 Amylonix AB Pharmaceuticals: MajorHealth Technology Amylonix AB develops pharmaceuticals focused on the neurodegenerative area. Amylonix AB is based in Johanneshov, Sweden. It was founded in 2018 by Karin Marianne Hansson, who has been the CEO since 2018. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Svezia | 21 |
| Stati Uniti | 2 |
| Finlandia | 2 |
Settori
| Health Technology | 11 |
| Consumer Services | 7 |
| Commercial Services | 5 |
| Finance | 3 |
Posizioni
| Corporate Officer/Principal | 7 |
| Graduate Degree | 6 |
| Director/Board Member | 4 |
| Chief Tech/Sci/R&D Officer | 4 |
| Director of Finance/CFO | 4 |
Contatti più connessi
- Borsa valori
- Insiders
- Bengt Norvik
- Connessioni Società
